Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 1

Current Treatment Options in Posterior Fossa Ependymomas

Posterior Fossa Ependimomalarında Güncel Tedavi Seçenekleri

Pages
38–42
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further biological studies are needed to identify targets that may be considered for clinical trials.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ependymomas represent the third most common childhood central nervous system neoplasm.
📊
Key Findings & Data:Literature has been reviewed using PubMed between 2008 to 2015 with the following key words.
💡
Conclusion & Impact:Further biological studies are needed to identify targets that may be considered for clinical trials.
🔬Design:Review & Systematic Survey
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Ependymomas represent the third most common childhood central nervous system neoplasm. They are typically midline tumors originating from the ependymal cells of the cerebral ventricles and more commonly occur in the posterior fossa. Literature has been reviewed using PubMed between 2008 to 2015 with the following key words. Ependymoma, new treatment, modalities, strategies. Complete surgical resection followed by radyotherapy remains the best therapeutic option in ependymoma cases. The techniques for intraoperative monitoring and mapping have been used recently. They are valuable tools to be employed when resecting ependymomas and can result in a significant lessening in operative morbidity. Various forms of radiation therapy have been used for teratment of the ependymomas recently, including stereotactic radiosurgery methods. It offers the theoretical advantages of delivering a high dose of radiation to a small target, providing a maximum dose to the tumor while avoiding surrounding critical brain structures and previously irradiated tissue. The role of chemotherapy for intracranial ependymoma is still uncertain. Based on the current literature, chemotherapeutic options for patients are limited. Further biological studies are needed to identify targets that may be considered for clinical trials.

Özet

Ependimoma, tüm santral sinir sistemi tümörleri içinde çocuklarda 3. sıklıkta görülen yaygın tümördür. Ependimoma genellikle posterior fossada yerleşip ventriküllerin ependimal hücrelerinden kaynaklanır. Yazın dizisi 2008 - 2015 yılları arası PubMed.com adresi kullanılarak "ependymoma, new treatment, modalities, strategies" sözcükleri ile arama yapıldı. Ependimomaların tedavisinde en iyi seçenek cerrahi olarak total çıkarmak ve ardından radyoterapi uygulamaktır. Son zamanlarda nörofizyolojik monitörizasyon, haritalama uygulamaları tanımlanmıştır. Bu teknikler yararlı uygulamalardır ve bunların kullanımı sonucunda son yıllarda ependimoma cerrahisinde mortalite oranları azalmıştır. Son yıllarda stereotaktik radyoterapi yöntemleri de dahil birçok radyoterapi yöntemi ependimoma tedavisinde kullanılır hale gelmiştir. Teorik avantajları çevre kritik dokulara zarar vermeden tümör dokusuna yüksek doz ışınlama yapabilmeleridir. Ependimoma tedavisinde kemoterapinin rolü hâlâ kesin değildir. Yazın dizisinde kemoterapi seçenekleri sınırlıdır. Ayrıca biyolojik çalışmalar klinik araştırmalar için gereken hedeflerini tanımlamak için gereklidir.

🔖

Cite This Article

SELÇUKİ, M., UMUR, A. Ş. (2022). Current Treatment Options in Posterior Fossa Ependymomas. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 1, 38–42. https://ajindex.com/articles/637417

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abbott R: The use of physiological mapping and monitoring during surgery for ependymomas. Childs Nerv Syst 25(10):1241-1247, 2009 2. Andreiuolo F, Ferreira C, Puget S, Grill J: Current and evolving knowledge of prognostic factors for pediatric ependymomas. Future Oncol 9(2):183-191, 2013 3. Bobola MS, Jankowski PP, Gross ME, Schwartz J, Finn LS, Blank A, Ellenbogen RG, Silber JR: Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma. Int J Cancer 129(10):2370-2379, 2011 4. Bouffet E, Capra M, Bartels U: Salvage chemotherapy for metastatic and recurrent ependymoma of childhood. Childs Nerv Syst 25(10):1293-1301, 2009 5. Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ: Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 20(22):5630-5640, 2014 6. Godfraind C: Classification and controversies in pathology of ependymomas. Childs Nerv Syst 25(10):1185-1193, 2009 7. Guan S, Shen R, Lafortune T, Tiao N, Houghton P, Yung WK, Koul D: Establishment and characterization of clinically relevant models of ependymoma: A true challenge for targeted therapy. Neuro Oncol 13(7):748-758,2011 8. Gururangan S, Fangusaro J, Young Poussaint T, OnarThomas A, Gilbertson RJ, Vajapeyam S, Gajjar A, Goldman S, Friedman HS, Packer RJ, Boyett JM, Kun LE, McLendon R: Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma-A Pediatric Brain Tumor Consortium study. Neuro Oncol 14(11):1404-1412,2012 9. Hadjipanayis CG, Van Meir EG. Brain cancer propagating cells: Biology, genetics and targeted therapies. Trends Mol Med 15(11):519-530,2009 10. Hoffman LM, Plimpton SR, Foreman NK, Stence NV, Hankinson TC, Handler MH, Hemenway MS, Vibhakar R, Liu AK: Fractionated stereotactic radiosurgery for recurrent ependymoma in children. J Neurooncol 116(1):107-111,2014 11. Karajannis M, Allen JC, Newcomb EW: Treatment of pediatric brain tumors. J Cell Physiol 217(3):584-589, 2008 12. Krieger MD, McComb JG: The role of stereotactic radiotherapy in the management of ependymomas. Childs Nerv Syst 25(10):1269-1273, 2009 13. MacDonald SM, Yock TI: Proton beam therapy following resection for childhood ependymoma. Childs Nerv Syst 26(3):285-291, 2010 14. Merchant TE: Three-dimensional conformal radiation therapy for ependymoma. Childs Nerv Syst 25(10):1261-1268, 2009 15. Mack SC, Taylor MD: The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 25(10):1195-120